Do You Get to Pick Gender in IVF? A Guide to Sex Selection Laws and Methods

Can you choose the sex of your baby during In Vitro Fertilization (IVF)? The short answer is: it entirely depends on where you stand geographically.

If you are asking this question from the United Kingdom, the immediate reality is strict. Under current regulations here, clinics cannot select embryos solely based on gender preference. However, across the Atlantic in the United States, private payers often have that freedom. This distinction creates a complex landscape for families dreaming of "family balancing"-the desire to have children of a specific gender to complete their picture.

While the biological science has existed for decades, the legal gates are locked differently in every country. Understanding the gap between what is medically possible and what is legally permitted is the first step before making any financial or emotional investment in treatment.

The Science Behind Selecting Embryo Sex

To understand why some people can pick gender and others cannot, we must look at the technology involved. The method used is typically called Preimplantation Genetic Testing (PGT). Specifically, a variation known as PGT-A or PGT-SR involves analyzing the chromosomal makeup of an embryo created via IVF before it is transferred to the uterus.

Every human embryo carries chromosomes that determine biological sex. Females have two X chromosomes (XX), while males have an X and a Y chromosome (XY). By using a procedure called biopsy, embryologists remove a few cells from the developing embryo-usually at the blastocyst stage, around day 5 or 6 of development.

These cells are then sent to a genetics lab. They sequence the DNA to look for specific chromosomal markers. Identifying whether an embryo is XX or XY is actually one of the easier things to detect genetically; there are plenty of markers on the Y chromosome that confirm male potential. If the clinic has permission to report this information to you, they can sort the viable embryos into groups: female candidates and male candidates.

This process does not change the success rate of pregnancy inherently, provided the embryo is healthy. However, the extra testing step costs significantly more than standard IVF cycles. It requires additional lab time, specialized equipment, and skilled geneticists to perform the analysis accurately.

How UK Law Regulates Gender Selection

Human Fertilisation and Embryology Authority (HFEA) acts as the independent regulator overseeing fertility treatment in the UK. Their stance on non-medical sex selection is clear and consistent.

You generally cannot choose the sex of your child for social reasons in Britain. The HFEA Code of Practice explicitly prohibits sex selection for non-medical purposes. This regulation was put in place to avoid gender discrimination and societal imbalance. The authorities believe that allowing parents to shop for a boy or a girl opens doors to harmful cultural practices and eugenics.

There is only one major exception to this rule: medical necessity. If there is a serious risk that a child of one sex would inherit a life-threatening genetic disease, doctors may be allowed to select the other sex. For instance, conditions like Duchenne Muscular Dystrophy are X-linked recessive disorders, meaning they almost exclusively affect boys.

In cases like that, selecting female embryos prevents the birth of a child who would suffer severe health issues later in life. Here, the gender choice is incidental to the goal of preventing disease. However, if you simply prefer a daughter to balance your three sons, UK clinics will not facilitate that request, regardless of how much you are willing to pay.

Alternatives Available Abroad

Families seeking non-medical sex selection often look beyond the UK. Several countries operate under different regulatory frameworks where "social gender selection" is legal. This has given rise to a form of reproductive tourism.

The United States is arguably the most popular destination for this type of treatment. Because there is no federal ban on sex selection, clinics have wide autonomy. However, ethical guidelines from the American Society for Reproductive Medicine (ASRM) suggest caution. While not illegal, many top-tier American academic centers still refuse to do it purely for social reasons, leaving the practice mostly to private commercial clinics.

Cosmetic sex selection comes with its own logistical hurdles. You would need to travel, possibly stay abroad for weeks during stimulation and egg retrieval, and deal with freezing embryos for later transfer back home-or transferring them locally in that country if laws allow.

Risks and Ethical Considerations

Selecting embryos sounds simple on paper, but it isn't risk-free. The primary physical risk lies in the biopsy procedure itself. Although modern techniques have improved safety margins significantly, there is always a tiny chance that removing cells could compromise the viability of the embryo.

Another risk is statistical probability. Even if you screen 10 embryos, you might find only two males and eight females, or vice versa. The distribution isn't always a neat 50/50 split in every batch. If none of your embryos survive the testing phase or if you run out of embryos with your desired gender before finding a viable one, the outcome could result in no pregnancy at all.

Psychologically, attaching importance to gender can become stressful. Parents may face pressure to meet societal expectations. There are also long-term demographic concerns raised by ethicists regarding population sex ratios, especially in cultures with heavy son-preference biases.

Beyond that, relying on technology to curate a child shifts the narrative of parenthood from acceptance to customization. Many counselors encourage prospective parents to focus on the health of the embryo rather than its chromosomal identity.

Understanding the Cost Difference

If you pursue an option where sex selection is permissible, expect a significant price hike. A standard IVF cycle in the UK typically costs between £5,000 to £8,000 when including medication. Add the layer of genetic testing, and the price jumps substantially.

The actual price varies wildly based on the lab fees and the number of embryos tested. Generally, you should anticipate paying an additional £3,000 to £6,000 just for the screening process per cycle. In the US, where PGT is standard practice, costs can go higher due to clinic overheads.

Furthermore, insurance rarely covers this expense. Health plans might cover the base IVF treatment if infertility is diagnosed, but the extra tests specifically required for gender identification fall squarely outside coverage. Most couples fund this through personal savings.

Before committing funds, ask your doctor for a breakdown of fees. Are there retesting fees if the results are inconclusive? Is freezing included? These hidden costs add up quickly.

Sperm Sorting as an Alternative?

Before diving into embryo testing, you might hear about sperm sorting methods, such as MicroSort. Unlike PGT, which looks at the embryo, sperm sorting attempts to separate X-carrying sperm (female) from Y-carrying sperm (male) before fertilization occurs.

In theory, this avoids the invasive embryo biopsy. However, the accuracy is lower compared to genetic testing on embryos. PGT claims near 100% accuracy, whereas sperm sorting is closer to 90% effective. It is rarely an option now due to better alternatives and limited availability.

Additionally, sperm sorting is not approved by the FDA for general clinical use in the US for decades, making it effectively unavailable in legitimate medical settings. Consequently, most couples looking for high certainty rely on PGT rather than older sorting techniques.